LBA1 Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study

Herbst R., de Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C., ...More

Annals of Oncology, vol.30, 2019 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 30
  • Publication Date: 2019
  • Doi Number: 10.1093/annonc/mdz453
  • Journal Name: Annals of Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Istanbul University-Cerrahpasa Affiliated: No